etoposide has been researched along with Retinoblastoma in 180 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.56) | 18.7374 |
| 1990's | 22 (12.22) | 18.2507 |
| 2000's | 64 (35.56) | 29.6817 |
| 2010's | 73 (40.56) | 24.3611 |
| 2020's | 20 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, WK; Jiang, Y; Yam, JC | 1 |
| Alexander, J; Coupland, SE; Jana, P; Kaliki, S; Kalirai, H; Kondapi, AK; Manukonda, R; Nair, RM; Narayana, RVL; Prabhu, V; Tomar, N; Vemuganti, GK | 1 |
| Kim, JK; Lee, C; Mao, Y; Sun, Y; Wu, Z; Zeng, J; Zhang, J; Zheng, J | 1 |
| Gemoll, T; Grisanti, S; Joachim, SC; Kakkassery, V; Kraemer, MM; Mergler, S; Ranjbar, M; Reinhard, J; Sauer, T; Tura, A | 1 |
| Alejos, A; Giron, V; Graff, Z; Luna-Fineman, S; Miller, K; Pixtun, D | 1 |
| Hao, W; Huang, J; Meng, X; Zhong, L; Zuo, Y | 1 |
| Alejos, A; Amador, G; Barnoya, M; Castellanos, ME; Chantada, G; Fu, L; Fuentes-Alabi, S; Girón, V; Goenz, MA; Luna-Fineman, S; Maldonado, C; Méndez, G; Morales, RA; Ortiz, R; Rodríguez-Galindo, C; Sanchez, G; Wilson, M | 1 |
| Albert, DM; Ali, MJ; Chévez-Barrios, P; Chintagumpala, M; Eagle, RC; Gao, Y; Honavar, SG; Khetan, V; Krailo, M; Leahey, AM; Matthay, K; Meadows, A; O'Brien, J; Piao, J; Vemuganti, G | 1 |
| Lu, L; Wang, Y; Yang, L; Zhang, L | 1 |
| Bas, Z; Dalvin, LA; Lally, SE; Leahey, A; Rao, R; Schwendeman, R; Shah, A; Shields, CL; Shields, JA; Tadepalli, S | 1 |
| Chen, Q; Dong, Y; Mo, X; Xia, J; Zhang, B; Zhang, J; Zhang, L; Zhang, S | 2 |
| Li, L; Li, R; Shao, RG; Song, WP; Wang, LW; Yao, HJ; Zhang, CY; Zhao, JY; Zheng, S; Zhou, XF | 1 |
| Balaji, S; Kim, U; Muthukkaruppan, V; Priya, CG; Santhi, R; Vanniarajan, A | 1 |
| Dick, HB; Faissner, A; Jarocki, M; Joachim, SC; Kakkassery, V; Krämer, MM; Reinhard, J; Wagner, N | 1 |
| Chintagumpala, M; Gombos, D; Huang, L; Jubran, RF; Krailo, M; Meadows, A; Murphree, AL; O'Brien, J; Piao, J; Shields, CL; Villablanca, JG | 1 |
| Bas, Z; Dalvin, LA; Pacheco, R; Rao, R; Shields, CL; Tadepalli, S; Vaidya, S | 1 |
| Aerts, I; Bertozzi, AI; Cassoux, N; Coze, C; Desjardins, L; Doz, F; Dupont, A; Levy-Gabriel, C; Lumbroso-Le Rouic, L; Russo, I; Savignoni, A | 1 |
| Bas, Z; Dalvin, LA; Leahey, AM; Rao, R; Shah, A; Shields, CL; Tadepalli, S | 1 |
| Busch, M; Dankert, JT; Dünker, N; Metz, K; Miroschnikov, N; Stephan, H; Wiesehöfer, M | 1 |
| Dinçaslan, H; Gündüz, AK; Mirzayev, I; Özalp Ateş, FS | 1 |
| Busch, M; Dräger, O; Dünker, N; Metz, K | 1 |
| Bechtold, M; Berry, JL; Jubran, R; Kim, JW; Reid, M; Shah, S; Zolfaghari, E | 1 |
| Chandra, A; Khetan, V; Krishnakumar, S; Natarajan, V; Sreelakshmi, KV | 1 |
| Gallie, B; Lambourne, M; MacDonald, H; Matevski, D; Racher, H; Soliman, SE | 1 |
| Faissner, A; Joachim, SC; Kakkassery, V; Kleuser, B; Kociok, N; Lüth, A; Reinhard, J; Skosyrski, S; Tate, R; van der Giet, M | 1 |
| Busch, M; Dünker, N; Papior, D; Stephan, H | 1 |
| Gupta, SK; Kumar, A; Pant, G; Pooniya, V; Verma, N | 1 |
| Malik, K; Shields, CL; Welch, RJ | 1 |
| Honavar, SG; Mulay, K; Rao, R; Reddy, VAP | 1 |
| Alcalde-Ruiz, E; Catala-Mora, J; Chantada, GL; Croxatto, JO; Dabezies, AP; de Dávila, MTG; Dufort, G; Fandiño, AC; Kopp, K; López, JP; Ossandon, D; Parareda-Salles, A; Pérez, V; Ravindranath, Y; Reaman, G; Rey, G; Sampor, C; Suñol, M; Urbieta, M; Zelter, M | 1 |
| Akyüz, C; Inam, O; Kiratli, H; Koç, İ; Varan, A | 1 |
| Dong, H; Fu, Y; Li, Q; Lu, X; Wang, M; Yang, G | 1 |
| Honavar, SG; Rao, R; Reddy, VP | 1 |
| Bakhshi, S; Chawla, B; Hada, M; Kashyap, S | 1 |
| Bornfeld, N; Eggert, A; Jurklies, C; Künkele, A; Lohmann, D; Schulte, JH; Wieland, R | 1 |
| All-Ericsson, C; Bartuma, K; Holm, S; Kosek, S; Pal, N | 1 |
| Abramson, DH; Brodie, SE; Francis, JH; Jonna, G; Liu, CY; Marr, BP | 1 |
| Kalpana, N; Narendran, V; Shah, PK | 1 |
| Honavar, SG; Khanna, R; Manjandavida, FP; Reddy, VA | 1 |
| Liu, F; Liu, Y; Wang, KL; Zhang, X | 1 |
| Bakhshi, S; Meel, R; Pushker, N; Vishnubhatla, S | 1 |
| Krishnakumar, S; Sreenivasan, S | 1 |
| Bornfeld, N; Eggert, A; Holdt, M; Künkele, A; Lohmann, D; Schulte, JH; Temming, P; Wilm, J | 1 |
| Johnston, WT; Kagame, K; Ndamira, A; Newton, R; Picton, SV; Revill, P; Simmons, IG; Twinamasiko, A; Waddell, KM | 1 |
| Elder, JE; Mathew, AA; McKenzie, JD; Sachdev, N; Staffieri, SE | 1 |
| Clerico, D; DiDomenico, C; Leahey, A | 1 |
| Aleieldin, A; Alfaar, AS; ElZomor, H; Fawzi, M; Kamel, A; Nour, R; Taha, H; Zaghloul, MS | 1 |
| Pointdujour-Lim, R; Samara, WA; Say, EA; Shields, CL | 1 |
| Bauer, JJ; Biewald, E; Bornfeld, N; Grasemann, C; Hauffa, BP; Hauffa, PK; Sauerwein, W; Schündeln, MM; Temming, P | 1 |
| Burris, C; Hungerford, JL; Kingston, J; Pavlidou, E; Reddy, MA; Sagoo, MS; Scheimberg, I; Thaung, C | 1 |
| Aerts, I; Algret, N; Bertozzi, AI; Cassoux, N; Desjardins, L; Doz, F; Esteve, M; Hajage, D; Lévy-Gabriel, C; Lumbroso-Le Rouic, L; Savignoni, A | 1 |
| Golubeva, OV; Gorovtsova, OV; Gorshkov, IM; Krivovyaz, OS; Polyakov, VG; Ushakova, TL; Yarovoy, AA | 1 |
| Narendran, V; Pandian, AJ; Shah, PK; Sripriya, S | 1 |
| Berry, JL; Jubran, R; Kim, JW; Lee, TC; Moysidis, SN; Murphree, AL; Shih, G; Wong, K | 1 |
| Chawla, B; Gupta, V; Hada, M; Kashyap, S; Narasimhaiah, PC; Sen, S; Seth, R | 1 |
| Buzzonetti, L; Cozza, R; De Ioris, MA; Natali, G; Romanzo, A; Valente, P | 1 |
| Ai, S; Chen, R; Ding, Y; Du, Y; Li, Q; Luo, X; Ma, W; Mao, Y; Yang, H; Ye, H | 1 |
| Azad, R; Chawla, B; Hasan, F; Pathy, S; Pattebahadur, R; Seth, R; Sharma, S; Upadhyaya, A | 1 |
| Beck-Popovic, M; Bergin, C; Gaillard, MC; Houghton, S; Mosimann, P; Munier, FL; Puccinelli, F; Stathopoulos, C | 1 |
| Chowdhury, T; Duncan, C; Fabian, ID; Johnson, KP; Onadim, Z; Reddy, MA; Sagoo, MS; Stacey, AW | 1 |
| Siddiqui, SN; Zafar, SN; Zaheer, N | 1 |
| Elner, VM; Harbour, JW; Mohney, BG; Musch, DC; Smith, AB; Smith, BD; Smith, SJ | 1 |
| Aziz, HA; Berry, JL; Jubran, R; Kim, JW; Kogachi, K; McGovern, K; Murphree, AL; Zolfaghari, E | 1 |
| Boeloeni, R; Bornfeld, N; Eggert, A; Schueler, A; Stephan, H | 1 |
| Chung, SE; Ham, DI; Koo, HH; Sa, HS; Sung, KW; Yoo, KH | 1 |
| Cohen, VM; Hungerford, JL; Kingston, J | 1 |
| Budning, A; Chan, HS; Dai, S; Dimaras, H; Doyle, J; Drake, J; Gallie, BL; Halliday, W; Héon, E | 1 |
| Hartzell, K; Leahey, A; Meadows, AT; Ramasubramanian, A; Shields, CL; Shields, JA; Thangappan, A | 1 |
| Atchaneeyasakul, LO; Sanpakit, K; Thephamongkhol, K; Trinavarat, A; Uiprasertkul, M; Wongsiwaroj, C | 1 |
| Bryar, PJ; Mets, MB; Parness-Yossifon, R; Srikumaran, D; Weinstein, JL | 1 |
| Leahey, A; Meadows, AT; Palamar, M; Ramasubramanian, A; Sharma, P; Shields, CL; Shields, JA | 1 |
| Chan, HS; Dimaras, H; Gallie, BL; Halliday, W; Héon, E; Khetan, V | 1 |
| Català-Mora, J; Medina-Zurinaga, M; Parareda-Salles, A; Prat-Bartomeu, J; Vicuña-Muñoz, CG | 1 |
| Abramson, DH; Chantada, GL; Dunkel, IJ; Finlay, JL; Goldman, S; Gururangan, S; Jubran, RF; Khakoo, Y; O'Brien, JM; Orjuela, M; Rodriguez-Galindo, C; Souweidane, MM | 1 |
| Budning, A; Chan, HS; Dimaras, H; Doyle, JJ; Gallie, BL; Halliday, W; Héon, E | 1 |
| Abramson, DH; Dunkel, IJ; Gardner, SL; Gershon, T; Gilheeney, S; Kernan, NA; Khakoo, Y; Lyden, DC; Orjuela, M; Wolden, SL | 1 |
| Nallasamy, S; Ramasubramanian, A; Shields, CL; Shields, JA; Tipperman, R | 1 |
| Aziz, HA; Aziz-Sultan, MA; Boutrid, H; Fernandes, CE; Houston, SK; Markoe, AM; Moftakhar, R; Murray, TG; Piña, Y; Reichbach, J; Schefler, AC; Wolfe, SQ | 1 |
| Patel, J; Shields, CL; Turaka, K | 1 |
| Ahn, HS; Kim, JH; Kim, JM; Kim, SJ; Park, KD; Shin, HY; Yu, YS | 1 |
| Chung, J; Shields, CL; Turaka, K | 1 |
| Fishman, M; Kim, JW; Moshfeghi, D; Yau, JW | 1 |
| Balwierz, W; Kobylarz, J; Moryl-Bujakowska, A; Pawińska-Wasikowska, K; Pietrys, D; Romanowska-Dixon, B | 1 |
| Babyn, P; Chan, HS; Dimaras, H; Doyle, J; Gallie, BL; Halliday, W; Héon, E; Paton, KE; Strahlendorf, C | 1 |
| Al-Futaisi, A; Al-Kharusi, N; Biswas, J; Ganesh, A; Khetan, V; Kumar, K; Raja, T | 1 |
| Grossniklaus, HE; Herwig, MC; Hubbard, GB; Wells, JR | 1 |
| Castillo, L; Chantada, GL; Diez, B; Dufort, G; Koop, K; Palma, J; Richard, L; Sampor, C; Sasso, DF | 1 |
| Leahey, A; Meadows, AT; Shields, CL; Turaka, K | 1 |
| Baez, F; Barnoya, M; Bonilla, M; Fu, L; Luna-Fineman, S; Rodríguez-Galindo, C | 1 |
| Eagle, RC; Kaliki, S; Leahey, A; Shah, SU; Shields, CL; Shields, JA | 1 |
| Damasco, VC; Dire, DJ | 1 |
| Cheng, Y; Dwarakanath, A; Garreis, F; Kakkassery, V; Kociok, N; Mergler, S; Pietrzak, P; Reinach, PS; Skosyrski, S | 1 |
| Aaberg, TM; Chevez-Barrios, P; Chintagumpala, M; Gao, W; Gombos, DS; Grossniklaus, HE; Hwang, CK; Paysse, E; Verner-Cole, E | 1 |
| Atchaneeyasakul, LO; Buaboonnam, J; Chiewvit, P; Sanpakit, K; Trinavarat, A | 1 |
| Bianciotto, CG; Iturralde, JC; Kaliki, S; Rojanaporn, D; Say, EA; Shields, CL | 1 |
| Harilal, A; Krishnakumar, S; Maheswari, UK; Mitra, M; Mohanty, C; Sahoo, SK | 1 |
| Akyüz, C; Aydın, B; Büyükpamukçu, M; Kiratli, H; Poyraz, CB; Tarlan, B; Varan, A | 1 |
| Chen, Z; Wu, L; Xing, Y; Zhang, J | 1 |
| Almarzouki, H; Bababeygy, SR; Berry, JL; Jubran, R; Kim, JW; Lee, TC; Murphree, AL; Wong, K | 1 |
| Ceciliano, A; Chantada, GL; Dominguez, J; Fandino, AC; Millan, N; Schaiquevich, P; Taich, P; Villasante, F | 1 |
| Faegh, A; Ghassemi, F; Karkhaneh, R; Rahmanikhah, E; Roohipoor, R | 1 |
| Bakhshi, S; Radhakrishnan, V; Sharma, S; Vishnubhatla, S | 1 |
| De Luca, M; Hadjistilianou, T; Lembo, A; Nucci, P; Pichi, F | 1 |
| Demirci, H; Honavar, SG; Meadows, AT; Naduvilath, TJ; Shields, CL; Shields, JA | 2 |
| Bornfeld, N; Havers, W; Heimann, H; Jurklies, C; Schueler, AO; Wieland, R | 1 |
| Behar, C; Bellaton, E; Bertozzi, AI; Brisse, H; Chastagner, P; Desjardins, L; Doz, F; Sainte-Rose, C | 1 |
| Beck, JD; Bornfeld, N; Havers, W; Klingebiel, T; Kremens, B; Neubert, D; Reinhard, H; Wieland, R | 1 |
| Benz, MS; Cicciarelli, N; Escalona-Benz, E; Feuer, W; Hayden, BC; Markoe, A; Murray, TG; Sussman, DA; Toledano, S | 1 |
| Ahn, HS; Choi, HS; Khwarg, SI; Kim, JH; Shin, HY; Yu, YS | 1 |
| Demirci, H; Eagle, RC; Shields, CL; Shields, JA | 1 |
| Antoneli, CB; Arias, V; Chojniak, MM; de Camargo, B; de Cássia Braga Ribeiro, K; Novaes, PE; Steinhorst, F | 1 |
| Cater, J; Meadows, AT; Shelil, A; Shields, CL; Shields, JA | 1 |
| Ekinci, C; Günalp, I; Gündüz, K; Taçyildiz, N; Unal, E; Yavuz, G | 1 |
| Casak, S; Chantada, G; Dávila, MT; Fandiño, A; Manzitti, J; Raslawski, E; Schvartzman, E | 1 |
| Demirci, H; Mashayekhi, A; Meadows, AT; Shields, CL; Shields, JA | 1 |
| Abramson, DH; Chantada, GL; Dunkel, IJ; Fandiño, AC | 1 |
| Cater, J; Mashayekhi, A; Meadows, AT; Shelil, A; Shields, CL; Shields, JA | 2 |
| Harbour, JW | 1 |
| Erden, E; Geyik, PO; Günalp, I; Gündüz, K; Taçyildiz, N; Unal, E; Yalçindağ, N | 1 |
| Lin, S; Mao, Y; Wu, Z; Yang, H; Zheng, J | 1 |
| Casak, SJ; Chantada, GL; de Dávila, MT; Fandiño, AC; Manzitti, J; Raslawski, EC; Schvartzman, E; Scopinaro, MJ | 1 |
| Bonci, E; Castello, MA; Clerico, A; Hadjistilianou, T; Ragni, G; Schiavetti, A | 1 |
| Burnier, MN; Caissie, AL; Erwenne, CM; Fernandes, LH; Martins, MC; Souza Filho, JP; Torres, VL | 1 |
| Cater, J; Mashayekhi, A; Meadows, AT; Ness, S; Shelil, A; Shields, CL; Shields, JA | 1 |
| Dyer, MA; Egorin, M; Gray, JK; Laurie, NA; Leggas, M; Relling, M; Stewart, C; Zhang, J | 1 |
| Demirci, H; Meadows, AT; Shields, CL; Shields, JA | 1 |
| Materin, MA; Shields, CL; Shields, JA | 1 |
| Antoneli, CB; Arias, VE; Chojniak, MM; Novaes, PE; Ribeiro, Kde C; Sakamoto, LH | 1 |
| Antoneli, CB; Chojniak, MM; Malogolowkin, M; Novaes, PE; Ribeiro, KC; Steinhorst, F | 1 |
| Antoneli, CB; Arias, V; Castilho, MS; Chojniak, MM; de Aguirre Neto, JC; Novaes, PE; Ribeiro, KB | 1 |
| Brichard, B; Chantrain, C; De Potter, P; Gala, JL; Sibille, C; Vermylen, C | 1 |
| Leahey, A; Manquez, ME; Meadows, AT; Shields, CL; Shields, JA; Sun, H | 1 |
| Friere, J; Komarnicky, L; Mashayekhi, A; Shields, CL; Shields, JA; Sun, H; Uysal, Y | 1 |
| Au, AK; Czyz, C; Leahey, A; Mashayekhi, A; Meadows, AT; Shields, CL; Shields, JA | 1 |
| Cicciarelli, N; Feuer, W; Murray, TG; Schefler, AC; Toledano, S | 1 |
| He, J; Huasheng, Y; Li, W; Mao, Y; Zheng, J; Zhongyao, W | 1 |
| Alagaratnam, J; Ariffin, H; George, TM; Ho, C; Ibrahim, H; Juraida, E; Khuzaiah, R; Menon, BS; Mohammad, M; Peng, LH | 1 |
| Lambert, MP; Meadows, AT; Shields, C | 1 |
| All-Ericsson, C; Economou, MA; Landau, I; Seregard, S; Träisk, F | 1 |
| Goldman, S; Greenwald, MJ; Mets, MB; Reitman, AJ; Seshadri, R; Strauss, LC; Weinstein, JL; Zage, PE; Zeid, JL | 1 |
| Aker, M; Charit, M; Pe'er, J; Pèer, J; Revel-Vilk, S; Weintraub, M | 1 |
| Antoneli, CB; Arias, VA; Chojniak, MM; Malogolowkin, M; Novaes, PE; Ribeiro, KB; Rodriguez-Galindo, C; Soares, FA | 1 |
| Aerts, I; Asselain, B; Bours, D; Dendale, R; Desjardins, L; Doz, F; Esteve, M; Lévy-Gabriel, C; Lumbroso-Le Rouic, L; Sastre, X | 1 |
| Fujiwara, Y; Inomata, M; Kaneko, A; Kawashima, K; Kunikane, H; Saijo, N; Tanaka, Y | 1 |
| Bouffet, E; Courbon, B; Desjardins, L; Doz, F; Gentet, JC; Mechinaud, F; Mosseri, V; Neuenschwander, S; Plantaz, D; Vannier, JP | 1 |
| Advani, SH; Iyer, RS; Kurkure, PA; Nair, CN; Pai, SK; Rao, SR | 1 |
| Goyal, R; Lueder, GT | 1 |
| Chantada, G; de Dávila, MT; Fandiño, A; Manzitti, J; Raslawski, E; Schvartzman, E | 1 |
| De Potter, P; Himelstein, BP; Maris, JM; Meadows, AT; Shields, CL; Shields, JA | 1 |
| Hungerford, JL; Kingston, JE; Madreperla, SA; Plowman, PN | 1 |
| Deegan, WF; Fisher, A; Gomer, CJ; Malogolowkin, M; Murphree, AL; Parker, R; Reed, E; Sato, JK; Villablanca, JG | 1 |
| De Potter, P; Needle, M; Shields, CL; Shields, JA | 1 |
| Armata, J; Grześkowiak-Melanowska, J; Skoczeń, S | 1 |
| Greenwald, MJ; Strauss, LC | 1 |
| El-Deiry, WS; Somasundaram, K | 1 |
| de Potter, P; Hamada, A; Kheterpal, S; Meadows, AT; Needle, M; Shields, CL; Shields, JA | 1 |
| Doughty, D; Hungerford, JL; Kingston, JE; Madreperla, SA; Plowman, PN; Singh, AD | 1 |
| Bouffet, E; Desjardins, L; Doz, F; Gentet, JC; Lutz, P; Michon, J; Namouni, F; Neuenschwander, S; Pacquement, H; Plantaz, D; Quintana, E; Tanguy, ML; Validire, P; Vannier, JP; Zucker, JM | 1 |
| Carabillò, M; Giuliano, M; Lauricella, M; Tesoriere, G; Vassallo, E; Vento, R | 1 |
| Emanuele, S; Giuliano, M; Lauricella, M; Tesoriere, G; Vento, R | 1 |
| Cater, J; Gross, N; Gündüz, K; Meadows, AT; Needle, M; Shields, CL; Shields, JA | 1 |
| Murray, TG; O'Brien, JM; Scott, IU; Toledano, S | 1 |
| Carabillò, M; Emanuele, S; Giuliano, M; Lauricella, M; Tesoriere, G; Vento, R | 1 |
| Asselain, B; Desjardins, L; Doz, F; Levy, C; Michon, J; Pacquement, H; Quintana, E; Schlienger, P; Validire, P; Zucker, JM | 1 |
| Bunin, GR; Friedman, DL; Himelstein, B; Meadows, AT; Miller, D; Needle, M; Shields, CL; Shields, JA | 1 |
| Benz, MS; Kramer, D; Murray, TG; Scott, IU; Toledano, S | 1 |
| Balmer, A; Beck, MN; Dessing, C; Munier, F; Pica, A | 1 |
| Beck, JD; Greil, J; Hertzberg, H; Kremens, B; Velten, I | 1 |
| Carvalho, C; Meadows, AT; Shields, CL; Shields, JA; Smith, AF | 1 |
| Nishimura, S; Sato, T; Ueda, H; Ueda, K | 1 |
| Coen, PG; Gombos, DS; Hungerford, JL; Kelly, A; Kingston, JE | 1 |
| Balmer, A; Munier, F; Zografos, L | 1 |
| Brichard, B; Cornu, G; De Bruycker, JJ; De Potter, P; Neven, B; Vermylen, C | 1 |
| Demirci, H; Friedman, DL; Honavar, SG; Meadows, AT; Naduvilath, TJ; Shields, CL; Shields, JA; Singh, A | 1 |
| Broxson, EH; Dole, MG; Dunkel, IJ; Filippa, DA; George, D; Heath, JA; Lyden, D | 1 |
| Hovi, L; Saarinen, UM; Sariola, H | 1 |
| Kuchiwaki, H; Mizuno, M; Shimosawa, S; Yoshida, J | 1 |
2 review(s) available for etoposide and Retinoblastoma
| Article | Year |
|---|---|
Trilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Female; Humans; Idarubicin; Ifosfamide; Male; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neoplastic Syndromes, Hereditary; Pinealoma; Prognosis; Retinoblastoma; Vincristine | 2007 |
[New strategies in the management of retinoblastoma].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Eye Enucleation; Eye, Artificial; Female; Fluorescein Angiography; Follow-Up Studies; Forecasting; Genetic Therapy; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Male; Neoadjuvant Therapy; Retinal Neoplasms; Retinoblastoma; Time Factors | 2002 |
25 trial(s) available for etoposide and Retinoblastoma
| Article | Year |
|---|---|
Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Macular Degeneration; Male; Non-Randomized Controlled Trials as Topic; Prognosis; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine; Visual Acuity | 2021 |
Randomized, controlled trial in groups C and D retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Vincristine | 2015 |
Pediatric Survivors of Retinoblastoma Are at Risk for Altered Bone Metabolism After Chemotherapy Treatment Early in Life.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Fractures, Bone; Humans; Male; Retinoblastoma; Risk Factors; Survivors; Vincristine; Vitamin D Deficiency | 2015 |
Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Male; Neoadjuvant Therapy; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine | 2016 |
Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Eye Enucleation; Female; Humans; Idarubicin; Infant; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Survival Analysis; Vincristine | 2016 |
Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America.
Topics: Antineoplastic Agents; Carboplatin; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Melphalan; Neoplasm Metastasis; Retinoblastoma; South America; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous | 2012 |
Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Eye Neoplasms; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Neoplasms, Second Primary; Retinoblastoma; Retrospective Studies; Survival Rate; Vincristine | 2012 |
Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central America; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Eye Neoplasms; Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Retinoblastoma; Survival Rate; Vincristine | 2012 |
Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Male; Retinal Neoplasms; Retinoblastoma; Vincristine | 2013 |
Chemoreduction for unilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine; Visual Acuity | 2002 |
Results of a prospective study for the treatment of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Idarubicin; Infant; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Optic Nerve Neoplasms; Prospective Studies; Retinoblastoma; Risk Factors; Scleral Diseases; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Practical approach to management of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Humans; Infant; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2004 |
Lack of activity of oral etoposide for relapsed intraocular retinoblastoma.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Child, Preschool; Etoposide; Humans; Infant; Neoplasm Recurrence, Local; Pilot Projects; Retinal Neoplasms; Retinoblastoma | 2004 |
Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Male; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Vincristine | 2004 |
Chemoreduction for intraocular retinoblastoma in Malaysia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryotherapy; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Infant; Laser Therapy; Malaysia; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine | 2007 |
Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Disease Progression; Etoposide; Eye Enucleation; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Laser Therapy; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Visual Acuity | 2008 |
Conservative treatments of intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Iodine Radioisotopes; Male; Neoadjuvant Therapy; Prospective Studies; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Treatment Outcome | 2008 |
Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Etoposide; Eye Neoplasms; Female; Follow-Up Studies; France; Humans; Infant; Male; Orbital Neoplasms; Remission Induction; Retinoblastoma | 1995 |
Results of a stage-based protocol for the treatment of retinoblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Eye Neoplasms; Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Prospective Studies; Retinoblastoma; Survival Analysis; Survival Rate; Vincristine | 1996 |
Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Diseases; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Seeding; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine; Vitreous Body | 1997 |
Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Laser Therapy; Male; Retinal Neoplasms; Retinoblastoma; Treatment Outcome | 1998 |
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine | 2000 |
First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; Male; Retinal Neoplasms; Retinoblastoma; Treatment Outcome | 2000 |
Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Eye Neoplasms; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm Seeding; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Treatment Outcome; Vincristine; Vitreous Body | 2002 |
Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Eye Enucleation; Female; Humans; Hyperthermia, Induced; Infant; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Failure; Treatment Outcome; Vincristine | 2002 |
153 other study(ies) available for etoposide and Retinoblastoma
| Article | Year |
|---|---|
Poly ADP Ribose Polymerase Inhibitor Olaparib Targeting Microhomology End Joining in Retinoblastoma Protein Defective Cancer: Analysis of the Retinoblastoma Cell-Killing Effects by Olaparib after Inducing Double-Strand Breaks.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA End-Joining Repair; Dose-Response Relationship, Drug; Etoposide; Humans; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Recombinational DNA Repair; Retinoblastoma; Retinoblastoma Protein | 2021 |
Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biological Availability; Carboplatin; Chromatography, High Pressure Liquid; Culture Media; Drug Carriers; Drug Delivery Systems; Etoposide; Flow Cytometry; Humans; Lactoferrin; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanoparticles; Neoplastic Stem Cells; Retinal Neoplasms; Retinoblastoma; Spectroscopy, Fourier Transform Infrared | 2021 |
Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy.
Topics: Animals; Cell Line, Tumor; Chromatin; Etoposide; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Methyltransferases; Mice; Retinal Neoplasms; Retinoblastoma | 2021 |
Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma.
Topics: Cell Line, Tumor; Etoposide; Humans; Proteomics; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Binding Proteins; Sphingolipids; Topoisomerase Inhibitors; Ubiquitin-Protein Ligases; Vascular Endothelial Growth Factor A | 2022 |
Toxicity and feasibility of vincristine, etoposide, and carboplatin alternating with vincristine, doxorubicin, and cyclophosphamide in children with advanced retinoblastoma in Guatemala.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Guatemala; Humans; Retinal Neoplasms; Retinoblastoma; Vincristine | 2023 |
Expression of YAP suppresses cell proliferation and elevates the sensitivity of chemotherapy in retinoblastoma cells through lipid-peroxidation induced ferroptosis.
Topics: Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; Cisplatin; Etoposide; Ferroptosis; Gene Expression Regulation, Neoplastic; Humans; Lipid Peroxidation; Lipids; MicroRNAs; Reactive Oxygen Species; Retinal Neoplasms; Retinoblastoma | 2023 |
Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central America; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoadjuvant Therapy; Neoplasm Staging; Progression-Free Survival; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Time Factors; Time-to-Treatment; Treatment Refusal; Vincristine | 2019 |
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; India; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Progression-Free Survival; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Assessment; Risk Factors; Time Factors; United States; Vincristine | 2019 |
lncRNA
Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Down-Regulation; Drug Resistance, Multiple; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Retinoblastoma; RNA, Long Noncoding; Vincristine | 2020 |
Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Male; Proportional Hazards Models; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2020 |
Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infusions, Intra-Arterial; Infusions, Intravenous; Intraocular Pressure; Male; Melphalan; Middle Aged; Prognosis; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Vincristine; Young Adult | 2020 |
Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism.
Topics: Antineoplastic Agents, Phytogenic; Drug Resistance, Neoplasm; Etoposide; Humans; Reelin Protein; Retinal Neoplasms; Retinoblastoma; RNA, Neoplasm; Transcriptome; Tumor Cells, Cultured | 2020 |
Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Carboplatin; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Humans; Multidrug Resistance-Associated Proteins; Nanog Homeobox Protein; Neoplasm Invasiveness; Neoplastic Stem Cells; Neural Stem Cells; Octamer Transcription Factor-3; Retinal Neoplasms; Retinoblastoma; Signal Transduction; SOXB1 Transcription Factors | 2020 |
Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Etoposide; Extracellular Matrix; Gene Expression; Humans; Matrix Metalloproteinases; Receptors, Cell Surface; Retinoblastoma; RNA, Messenger; Tissue Inhibitor of Metalloproteinases | 2020 |
A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Prognosis; Retinal Neoplasms; Retinoblastoma; Tenon Capsule; Vincristine; Young Adult | 2020 |
Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Fluorescein Angiography; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Ultrasonography; Vincristine | 2020 |
Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Humans; Infant; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2021 |
Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
Topics: 3' Untranslated Regions; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Protein Binding; Retinal Neoplasms; Retinoblastoma; Retinoic Acid Receptor alpha | 2021 |
Recurrence and new tumor development after frontline intravenous chemotherapy for retinoblastoma: Risk factors and treatment results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Infant; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Treatment Outcome | 2022 |
Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chickens; Child; Etoposide; Humans; Neural Cell Adhesion Molecule L1; Retinal Neoplasms; Retinoblastoma | 2022 |
Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cryotherapy; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Intravitreal Injections; Laser Coagulation; Male; Melphalan; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Vincristine; Vitreous Body | 2017 |
Anterior Chamber Invasion in Retinoblastoma: Not an Indication for Adjuvant Chemotherapy.
Topics: Anterior Chamber; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Invasiveness; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Survival Rate; Vincristine | 2017 |
A novel deep intronic low penetrance RB1 variant in a retinoblastoma family.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infant; Introns; Mutation; Pedigree; Penetrance; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Binding Proteins; Ubiquitin-Protein Ligases; Vincristine; Young Adult | 2018 |
Etoposide Upregulates Survival Favoring Sphingosine-1-Phosphate in Etoposide-Resistant Retinoblastoma Cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Etoposide; Humans; Lysophospholipids; Retinoblastoma; Sphingosine; Tumor Cells, Cultured | 2019 |
Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chickens; Chorioallantoic Membrane; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Humans; Neoplasm Transplantation; Retinal Neoplasms; Retinoblastoma | 2018 |
Outcome of extraocular retinoblastoma in a resource limited center from low middle income country.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; India; Infant; Male; Neoadjuvant Therapy; Registries; Retinoblastoma; Retrospective Studies; Survival Rate; Vincristine | 2017 |
HAND-HELD OPTICAL COHERENCE TOMOGRAPHY MONITORING OF CHEMORESISTANT RETINOBLASTOMA.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infant; Infusions, Intra-Arterial; Infusions, Intravenous; Retinal Neoplasms; Retinoblastoma; Tomography, Optical Coherence; Vincristine | 2020 |
Eye salvage in diffuse anterior retinoblastoma using systemic chemotherapy with periocular and intravitreal topotecan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Etoposide; Gonioscopy; Humans; Infant; Infusions, Intravenous; Intravitreal Injections; Male; Microscopy, Acoustic; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan; Vincristine | 2018 |
Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; Hydrophthalmos; Idarubicin; Infant; Male; Mesna; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Survival Rate; Vincristine | 2018 |
Retrospective analysis of primarily treated group D retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cryotherapy; Etoposide; Eye Enucleation; Female; Humans; Infant; Infant, Newborn; Infusions, Intra-Arterial; Infusions, Intravenous; Intravitreal Injections; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Vincristine | 2018 |
miR‑34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE‑A/p53 signaling.
Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Child, Preschool; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infant; Male; Melanoma-Specific Antigens; MicroRNAs; Retinal Neoplasms; Retinoblastoma; Signal Transduction; Tumor Suppressor Protein p53; Vincristine | 2019 |
Preservation of retinoblastoma group E eyes with neovascular glaucoma using intravenous chemotherapy: risk factors and outcomes.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Glaucoma, Neovascular; Humans; Infant; Infusions, Intravenous; Intraocular Pressure; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Salvage Therapy; Treatment Outcome; Vincristine; Visual Acuity | 2019 |
Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheterization; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infusions, Intra-Arterial; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2019 |
Orbital retinoblastoma in an adult.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Combined Modality Therapy; Etoposide; Exophthalmos; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Orbital Neoplasms; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Ultrasonography; Vincristine; Young Adult | 2013 |
Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cyclophosphamide; Disease Progression; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine; Visual Acuity | 2013 |
A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity | 2014 |
Non-selectivity of ERG reductions in eyes treated for retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Color Vision; Electroretinography; Etoposide; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Night Vision; Photic Stimulation; Retina; Retinal Neoplasms; Retinoblastoma; Vincristine | 2014 |
Outcomes of Intra- and Extraocular Retinoblastomas from a Single Institute in South India.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Developing Countries; Etoposide; Eye Enucleation; Female; Humans; India; Infant; Infant, Newborn; Male; Outcome Assessment, Health Care; Proton Therapy; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Vincristine | 2015 |
Management and outcome of retinoblastoma with vitreous seeds.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Male; Neoplasm Seeding; Radiotherapy, Adjuvant; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity; Vitreous Body | 2014 |
Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma.
Topics: Administration, Topical; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Male; Prognosis; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2014 |
Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Topics: Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Caspase 3; Cell Cycle; Cell Line, Tumor; Curcumin; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Humans; Retinal Neoplasms; Retinoblastoma; Vincristine | 2015 |
Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Etoposide; Eye Enucleation; Female; Germany; Humans; Infant; Male; Neoadjuvant Therapy; Proton Therapy; Referral and Consultation; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Survival Rate; Vincristine; Vitrectomy | 2015 |
Improving survival of retinoblastoma in Uganda.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Delayed Diagnosis; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Neoadjuvant Therapy; Proportional Hazards Models; Retinal Neoplasms; Retinoblastoma; Survival Rate; Uganda; Vincristine | 2015 |
Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cyclophosphamide; Etoposide; Eye Enucleation; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Male; Microscopy, Acoustic; Orbital Neoplasms; Retinal Neoplasms; Retinoblastoma; Vincristine | 2015 |
Lack of vincristine infiltrates in patients with retinoblastoma receiving chemotherapy by peripheral intravenous lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2015 |
High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Developing Countries; Egypt; Etoposide; Eye Enucleation; Humans; Infant; Neoplasm Invasiveness; Optic Nerve Neoplasms; Prevalence; Retinal Neoplasms; Retinoblastoma; Risk Factors; Vincristine | 2015 |
Foveal microanatomy documented by SD-OCT following treatment of advanced retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fovea Centralis; Humans; Infant; Male; Microscopy, Acoustic; Retinal Detachment; Retinal Neoplasms; Retinoblastoma; Tomography, Optical Coherence; Vincristine; Visual Acuity | 2015 |
Anterior Segment Seeding in Eyes With Retinoblastoma Failing to Respond to Intraophthalmic Artery Chemotherapy.
Topics: Adolescent; Anterior Eye Segment; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Neoplasm Seeding; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Failure; Vincristine | 2015 |
Intraocular surgery with melphalan irrigation for vitreous hemorrhage in an only eye with retinoblastoma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Combined Modality Therapy; Cryotherapy; Cyclophosphamide; Dacarbazine; Endotamponade; Etoposide; Humans; Infant; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Silicone Oils; Therapeutic Irrigation; Vincristine; Visual Acuity; Vitrectomy; Vitreous Hemorrhage | 2015 |
Prenatal genetic diagnosis of retinoblastoma and report of RB1 gene mutation from India.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; DNA Mutational Analysis; Etoposide; Exons; Female; Genes, Retinoblastoma; Genetic Predisposition to Disease; Genetic Testing; Germ-Line Mutation; Humans; India; Infant; Pedigree; Prenatal Diagnosis; Proton Therapy; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Binding Proteins; Ubiquitin-Protein Ligases; Vincristine | 2016 |
Patterns of subretinal fluid resolution in Group D eyes treated with chemoreduction: Experience from the Children's Hospital Los Angeles/University of Southern California.
Topics: Academic Medical Centers; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Hospitals, Pediatric; Humans; Los Angeles; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Subretinal Fluid; Time Factors; Vincristine | 2016 |
Trabeculectomy in eyes with unsuspected retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Glaucoma; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Trabecular Meshwork; Trabeculectomy; Uveal Neoplasms; Vincristine | 2016 |
Advanced unilateral retinoblastoma: a case of sparing enucleation treatment failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Fluorescein Angiography; Humans; Infusions, Intra-Arterial; Intravitreal Injections; Magnetic Resonance Imaging; Male; Melphalan; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Seeding; Optic Nerve Neoplasms; Retinal Neoplasms; Retinoblastoma; Treatment Failure | 2016 |
The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
Topics: Antineoplastic Agents; Carboplatin; Child, Preschool; China; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Male; Neoplasm Staging; Postoperative Care; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Vincristine | 2016 |
First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of
Topics: Aftercare; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Humans; Infant; Infusions, Intra-Arterial; Infusions, Intravenous; Melphalan; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vision Disorders | 2017 |
Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Humans; Infant; Infant, Newborn; Infusions, Intra-Arterial; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Vincristine | 2017 |
Tumor Regression Patterns in Retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Female; Humans; Infant; Lasers, Semiconductor; Male; Neoplasm Staging; Pakistan; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vincristine | 2016 |
Preclinical Acute Ocular Safety Study of Combined Intravitreal Carboplatin and Etoposide Phosphate for Retinoblastoma.
Topics: Animals; Antineoplastic Agents; Carboplatin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroretinography; Etoposide; Intravitreal Injections; Male; Neoplasms, Experimental; Ophthalmoscopy; Organophosphorus Compounds; Rabbits; Retina; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Visual Acuity | 2017 |
Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Prognosis; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Salvage Therapy; Vincristine | 2017 |
Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines.
Topics: Antineoplastic Agents, Phytogenic; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Humans; Osmolar Concentration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Neoplasms; Retinoblastoma; Verteporfin | 2008 |
Clinical manifestations and treatment of retinoblastoma in Korea.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye; Eye Enucleation; Female; Humans; Infant; Korea; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine | 2008 |
The success of primary chemotherapy for group D heritable retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Germ-Line Mutation; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Protein; Treatment Outcome; Vincristine | 2009 |
Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Etoposide; Fatal Outcome; Female; Gestational Age; Humans; Hypothalamic Diseases; Infant; Infusions, Parenteral; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Protein; Tomography, X-Ray Computed; Topotecan; Vincristine | 2008 |
Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity | 2009 |
Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Laser Coagulation; Male; Prognosis; Retinal Neoplasms; Retinoblastoma; Survival Rate; Thailand; Treatment Outcome; Vincristine | 2009 |
Sudden dispersion of retinoblastoma shortly after initial chemotherapy treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Infant; Male; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Vincristine; Vitreous Body | 2009 |
Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcinosis; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2009 |
Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Calcinosis; Carboplatin; Child, Preschool; Cyclosporine; Etoposide; Eye Enucleation; Humans; Male; Retinal Diseases; Retinal Neoplasms; Retinoblastoma; Vincristine | 2009 |
[Uveitis masquerade syndrome as a presenting form of diffuse retinoblastoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aqueous Humor; Biomarkers, Tumor; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Eye Neoplasms; Humans; L-Lactate Dehydrogenase; Male; Neoplasm Invasiveness; Neoplasm Proteins; Retinoblastoma; Syndrome; Uveitis, Intermediate; Vincristine | 2009 |
Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Meningeal Neoplasms; Pineal Gland; Pinealoma; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2010 |
Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Cerebrospinal Fluid; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cytarabine; Etoposide; Eye Enucleation; Humans; Infant; Male; Prognosis; Retinal Neoplasms; Retinoblastoma; Transplantation, Autologous; Treatment Outcome; Vincristine | 2009 |
Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neoplasm Staging; Recurrence; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Analysis; Transplantation, Autologous; Vincristine | 2010 |
Chemoreduction for nonvisualized retinoblastoma hidden behind dense cataract.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cataract; Cataract Extraction; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Magnetic Resonance Imaging; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 2010 |
Ophthalmic vasculature alterations following systemic chemotherapy and periocular Carboplatin treatment of advanced retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Cancer, Regional Perfusion; Child, Preschool; Combined Modality Therapy; Cyclosporine; Etoposide; Female; Fluorescein Angiography; Humans; Infant; Injections, Intra-Arterial; Laser Coagulation; Ophthalmic Artery; Retinal Artery; Retinal Neoplasms; Retinoblastoma; Sclerosis; Vincristine | 2010 |
Resolution of iris neovascularization following chemoreduction of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Humans; Iris; Neovascularization, Pathologic; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Ultrasonography; Vincristine; Visual Acuity | 2010 |
Visual prognosis of retinoblastoma in the posterior pole treated with primary chemotherapy plus local treatments.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Eyeglasses; Female; Follow-Up Studies; Fovea Centralis; Humans; Infant; Male; Prognosis; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Visual Acuity | 2010 |
Retinocytoma shows lack of response to chemoreduction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Esotropia; Etoposide; Female; Humans; Magnetic Resonance Imaging; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine; Visual Acuity; Vitreous Body | 2010 |
Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Eye Enucleation; Female; Fibrosis; Humans; Infant; Injections, Intraocular; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Seeding; Orbit; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Vincristine | 2010 |
[Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cryotherapy; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Infant; Infant, Newborn; Light Coagulation; Male; Retinoblastoma; Treatment Outcome; Vincristine | 2010 |
Multifaceted chemotherapy for trilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pineal Gland; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Topotecan; Vincristine | 2011 |
Diffuse infiltrating retinoblastoma with central nervous system metastasis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Etoposide; Humans; Hydrocortisone; Infusions, Intravenous; Injections, Spinal; Magnetic Resonance Imaging; Male; Methotrexate; Retinal Neoplasms; Retinoblastoma; Vincristine | 2011 |
[Diffuse anterior retinoblastoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Humans; Male; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2011 |
Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Invasiveness; Optic Nerve Neoplasms; Postoperative Care; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Treatment Outcome; Uveal Neoplasms; Vincristine | 2011 |
A child with leukocoria.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Carboplatin; Child, Preschool; Diagnosis, Differential; Emergencies; Etoposide; Eye Abnormalities; Eye Enucleation; Eye Neoplasms; Eye Pain; Humans; Male; Pupil Disorders; Remission Induction; Retinal Diseases; Retinoblastoma; Vincristine | 2011 |
Altered calcium regulation by thermosensitive transient receptor potential channels in etoposide-resistant WERI-Rb1 retinoblastoma cells.
Topics: Calcium; Capsaicin; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Microscopy, Fluorescence; Patch-Clamp Techniques; Real-Time Polymerase Chain Reaction; Receptor, Cannabinoid, CB1; Retinal Neoplasms; Retinoblastoma; RNA, Messenger; Transient Receptor Potential Channels | 2012 |
Residual intraretinal retinoblastoma after chemoreduction failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm, Residual; Retinal Neoplasms; Retinoblastoma; Treatment Failure; Ultrasonography; Vincristine | 2012 |
Selective ophthalmic arterial infusion of chemotherapeutic drugs for recurrent retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cryotherapy; Electrophysiology; Electroretinography; Etoposide; Female; Humans; Infusions, Intra-Arterial; Melphalan; Neoplasm Recurrence, Local; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2012 |
Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Infant; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Melphalan; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vincristine | 2012 |
A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs.
Topics: Antineoplastic Agents; Biocompatible Materials; Carboplatin; Cell Culture Techniques; Cell Proliferation; Cell Survival; Diffusion; Doxorubicin; Etoposide; Extracellular Matrix; Gene Expression Profiling; Humans; Inhibitory Concentration 50; Kinetics; Lactic Acid; MicroRNAs; Nanoparticles; Oligonucleotide Array Sequence Analysis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Retinoblastoma; Tissue Engineering; Tissue Scaffolds | 2012 |
The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2012 |
Effect of miR-513a-5p on etoposide-stimulating B7-H1 expression in retinoblastoma cells.
Topics: B7-H1 Antigen; Cell Line, Tumor; Etoposide; Gene Expression; Humans; MicroRNAs; Retinoblastoma | 2012 |
Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Child, Preschool; Etoposide; Humans; Infant; Radiotherapy, Intensity-Modulated; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2013 |
Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Topics: Administration, Intravenous; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Injections, Intra-Arterial; Injections, Intraocular; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Topotecan; Treatment Outcome; Vincristine; Young Adult | 2013 |
MRI findings at baseline and after neoadjuvant chemotherapy in orbital retinoblastoma (IRSS stage III).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasm Staging; Optic Nerve Neoplasms; Orbit; Prospective Studies; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Survival Rate; Vincristine | 2013 |
Bilateral retinoblastoma: clinical presentation, management and treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Eye Enucleation; Female; Humans; Ifosfamide; Infant; Retinal Neoplasms; Retinoblastoma; Treatment Outcome | 2013 |
Thermochemotherapy in hereditary retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Treatment Outcome; Vincristine | 2003 |
Neoadjuvant chemotherapy for extensive unilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Hydrophthalmos; Infant; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Optic Nerve Neoplasms; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed | 2003 |
High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Male; Recurrence; Retinoblastoma; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2003 |
Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Rate; Time Factors; Vincristine | 2003 |
Clinical result of prolonged primary chemotherapy in retinoblastoma patients.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Drug Administration Schedule; Etoposide; Eye Enucleation; Humans; Ifosfamide; Infant; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Ultrasonography; Vincristine | 2003 |
Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Vincristine | 2003 |
Extraocular retinoblastoma: a 13-year experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Eye Enucleation; Female; Humans; Ifosfamide; Male; Retinal Neoplasms; Retinoblastoma; Teniposide; Time Factors; Vincristine | 2003 |
Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Survival Rate; Vincristine | 2003 |
Encouraging result of tamoxifen in a retinoblastoma patient with central nervous system metastasis.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Glucocorticoids; Humans; Meningeal Neoplasms; Methotrexate; Retinoblastoma; Skull Neoplasms; Tamoxifen; Vincristine | 2003 |
What is the best treatment for retinoblastoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Humans; Hyperthermia, Induced; Infant; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Vincristine | 2004 |
Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye Enucleation; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Seeding; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Factors; Treatment Failure; Vincristine | 2004 |
Measurement of intraocular concentrations of etoposide after systemic and local administration.
Topics: Administration, Topical; Animals; Antineoplastic Agents, Phytogenic; Aqueous Humor; Biological Availability; Conjunctiva; Etoposide; Eye; Infusions, Intravenous; Injections; Rabbits; Retinal Neoplasms; Retinoblastoma; Tissue Distribution; Vitreous Body | 2004 |
Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Developing Countries; Etoposide; Eye Enucleation; Humans; Radiotherapy; Retinoblastoma; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Conservative therapy in intraocular retinoblastoma: response/recurrence rate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cryotherapy; Etoposide; Humans; Laser Therapy; Middle Aged; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome | 2005 |
Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Eye Enucleation; Female; Humans; Hyperthermia, Induced; Infant; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Risk Assessment; Risk Factors; Vincristine | 2004 |
Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brachytherapy; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Immunoenzyme Techniques; Infant; Male; Neoplasm Invasiveness; Retinal Neoplasms; Retinoblastoma; Vincristine | 2005 |
Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Infant; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2005 |
Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Topics: Animals; Animals, Newborn; Antineoplastic Agents; Apoptosis; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Etoposide; Eye; Humans; Mice; Mice, Knockout; Rats; Retinal Neoplasms; Retinoblastoma; Time Factors; Topotecan; Vincristine; Xenograft Model Antitumor Assays | 2005 |
Long-term visual outcome following chemoreduction for retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity | 2005 |
Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryotherapy; Etoposide; Female; Fovea Centralis; Humans; Hyperthermia, Induced; Infant; Retinal Detachment; Retinal Neoplasms; Retinoblastoma; Tomography, Optical Coherence; Vincristine; Visual Acuity | 2005 |
Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine | 2006 |
Retinoblastoma in children older than 5 years of age.
Topics: Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Brazil; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Laser Coagulation; Male; Neoplasm Invasiveness; Neoplasm Staging; Radiotherapy, Adjuvant; Retinoblastoma; Teniposide; Treatment Outcome; Vincristine | 2007 |
Retinoblastoma and deletion of the long arm of chromosome 13: an underestimated diagnosis?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Deletion; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 8; Combined Modality Therapy; Etoposide; Eye Enucleation; False Negative Reactions; Female; Genes, Retinoblastoma; Humans; Hyperthermia, Induced; In Situ Hybridization, Fluorescence; Infant; Neoplasms, Multiple Primary; Remission Induction; Retinal Neoplasms; Retinoblastoma; Skull; Translocation, Genetic; Vincristine | 2008 |
Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Fluorescein Angiography; Glaucoma, Neovascular; Humans; Infant; Iris; Neovascularization, Pathologic; Retinal Neoplasms; Retinoblastoma; Vincristine | 2006 |
Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child; Etoposide; Eye Diseases; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Survival Analysis; Vincristine | 2006 |
The International Classification of Retinoblastoma predicts chemoreduction success.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Humans; Hyperthermia, Induced; Infant; International Classification of Diseases; Reproducibility of Results; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 2006 |
Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Intraoperative Complications; Laser Therapy; Male; Neoplasm Recurrence, Local; Postoperative Complications; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Visual Acuity | 2007 |
The experiment research of subconjunctival injections with etoposide for the treatment of retinoblastoma mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Conjunctiva; Dose-Response Relationship, Drug; Etoposide; Mice; Mice, Inbred BALB C; Mice, Nude; Retinal Neoplasms; Retinoblastoma | 2005 |
A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Evoked Potentials, Auditory, Brain Stem; Hearing; Hearing Loss; Humans; Infant; Infant, Newborn; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2008 |
Uveitis masquerade syndromes: diffuse retinoblastoma in an older child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Diagnosis, Differential; Etoposide; Eye Enucleation; Humans; Male; Retinal Neoplasms; Retinoblastoma; Syndrome; Tomography, X-Ray Computed; Ultrasonography; Uveitis; Vincristine | 2007 |
Secondary acute myeloid leukemia after etoposide therapy for retinoblastoma.
Topics: Acute Disease; Antineoplastic Agents, Phytogenic; Etoposide; Female; Humans; Infant; Leukemia, Myeloid; Retinal Neoplasms; Retinoblastoma; Treatment Outcome | 2007 |
The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Retinal Neoplasms; Retinoblastoma; Sex Distribution; Survival Rate; Teniposide | 2007 |
Induction of apoptosis in cultured retinoblastoma cells by the protein phosphatase inhibitor, okadaic acid.
Topics: Apoptosis; Calcimycin; Cell Cycle; Cell Survival; Child, Preschool; Cholera Toxin; Colforsin; DNA, Neoplasm; Enzyme Inhibitors; Ethers, Cyclic; Etoposide; Flow Cytometry; HL-60 Cells; Humans; Male; Mitosis; Nocodazole; Okadaic Acid; Paclitaxel; Phosphoprotein Phosphatases; Retinoblastoma; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured | 1995 |
Pilot study of sequential combination chemotherapy in advanced and recurrent retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Eye Neoplasms; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neutropenia; Pilot Projects; Remission Induction; Retinoblastoma | 1994 |
Visual function after laser hyperthermia and chemotherapy for macular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Eye Neoplasms; Female; Humans; Hyperthermia, Induced; Infant; Lasers; Macula Lutea; Retinoblastoma; Vincristine; Visual Acuity | 1996 |
Chemoreduction in the initial management of intraocular retinoblastoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Eye Neoplasms; Female; Fundus Oculi; Humans; Infant; Male; Pilot Projects; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction; Retinoblastoma; Vincristine | 1996 |
Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Glaucoma, Neovascular; Humans; Infant; Male; Neoplasm Recurrence, Local; Retinoblastoma; Survival Rate; Vincristine; Visual Acuity | 1996 |
Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
Topics: Animals; Anterior Chamber; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Combined Modality Therapy; Cryotherapy; DNA Adducts; DNA, Neoplasm; Etoposide; Eye Enucleation; Eye Neoplasms; Humans; Hyperthermia, Induced; Iodine Radioisotopes; Laser Coagulation; Melanoma; Rabbits; Retinoblastoma; Vincristine | 1996 |
Bilateral macular retinoblastoma managed by chemoreduction and chemothermotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryotherapy; Etoposide; Eye Neoplasms; Female; Fundus Oculi; Humans; Hyperthermia, Induced; Infant, Newborn; Macula Lutea; Retinoblastoma; Vincristine | 1996 |
What is the best method of prevention of therapeutic failures in CNS in high risk retinoblastoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child, Preschool; Chlorambucil; Etoposide; Humans; Male; Orbital Neoplasms; Prednisolone; Retinoblastoma; Risk Factors; Vincristine | 1997 |
Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
Topics: Antineoplastic Agents; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Fundus Oculi; Humans; Hypothermia, Induced; Infant; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Remission Induction; Retinoblastoma | 1996 |
Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
Topics: Acetyltransferases; Adenovirus E1A Proteins; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Cycle Proteins; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; DNA, Neoplasm; Doxorubicin; Enzyme Inhibitors; Etoposide; Histone Acetyltransferases; Humans; Lung Neoplasms; p300-CBP Transcription Factors; Retinoblastoma; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1997 |
Treatment of retinoblastoma vitreous base seeding.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Iridium Radioisotopes; Male; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine; Vitreous Body | 1998 |
High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Diseases; Male; Neutropenia; Retinal Neoplasms; Retinoblastoma | 1997 |
Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors.
Topics: Amsacrine; Apoptosis; bcl-2-Associated X Protein; Camptothecin; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cycloheximide; Dactinomycin; DNA Damage; DNA Topoisomerases, Type I; DNA, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Insulin-Like Growth Factor Binding Protein 3; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Apoptotic effects of different drugs on cultured retinoblastoma Y79 cells.
Topics: Amsacrine; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Butyrates; Butyric Acid; Camptothecin; Carboplatin; Cisplatin; DNA Damage; Drug Screening Assays, Antitumor; Etoposide; Humans; Paclitaxel; Retinoblastoma; Suramin; Tumor Cells, Cultured | 1998 |
The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child, Preschool; Cryosurgery; Drug Administration Schedule; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Infant; Laser Coagulation; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Treatment Outcome; Vincristine | 1998 |
New retinoblastoma tumors in children undergoing systemic chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cryotherapy; Etoposide; Female; Fundus Oculi; Humans; Hyperthermia, Induced; Infant; Male; Neoplasms, Second Primary; Retinal Neoplasms; Retinoblastoma; Vincristine | 1998 |
Increased cyclin E level in retinoblastoma cells during programmed cell death.
Topics: Amsacrine; Apoptosis; Camptothecin; Cyclin A; Cyclin E; Enzyme Inhibitors; Etoposide; Humans; Interleukin-1; Retinoblastoma; Sphingosine; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1998 |
Complications of systemic chemotherapy as treatment of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclosporine; Cytarabine; Etoposide; Female; Fever; Humans; Infant; Male; Methotrexate; Neutropenia; Organophosphorus Compounds; Retinal Neoplasms; Retinoblastoma; Thrombocytopenia; Vincristine | 2000 |
Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation.
Topics: Antigens, CD34; Antineoplastic Agents; Bone Marrow Neoplasms; Bone Neoplasms; Carboplatin; Child; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Recurrence; Remission Induction; Retinoblastoma; Thiotepa; Transplantation, Autologous; Vincristine | 2001 |
Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Male; Pinealoma; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Vincristine | 2001 |
Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Retinal Neoplasms; Retinoblastoma | 2001 |
Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Regression Analysis; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2002 |
Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Cryotherapy; Etoposide; Eye Enucleation; Female; Humans; Hyperthermia, Induced; Infant; Male; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Vincristine | 2002 |
Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
Topics: Acyclovir; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Epstein-Barr Virus Infections; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methylprednisolone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Optic Nerve Neoplasms; Radiotherapy, Adjuvant; Retinoblastoma; Rituximab; Thiotepa; Vincristine | 2002 |
Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Bone Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Gangliosides; Humans; Mandibular Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Remission Induction; Retinoblastoma; Transplantation, Autologous; Vincristine; Whole-Body Irradiation | 1991 |
[Intracranial fibrosarcoma fifteen years after radiotherapy in bilateral retinoblastomas: effect of combined chemotherapy with cisplatin and VP-16].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Eye Neoplasms; Fibrosarcoma; Frontal Lobe; Humans; Male; Neoplasms, Radiation-Induced; Orbital Neoplasms; Radiotherapy; Retinoblastoma | 1989 |